Development and External Validation of a Prognostic Nomogram for Metastatic Uveal Melanoma

BACKGROUND: Approximately 50% of patients with uveal melanoma (UM) will develop metastatic disease, usually involving the liver. The outcome of metastatic UM (mUM) is generally poor and no standard therapy has been established. Additionally, clinicians lack a validated prognostic tool to evaluate th...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:PLoS One
Asıl Yazarlar: Valpione, Sara, Moser, Justin C., Parrozzani, Raffaele, Bazzi, Marco, Mansfield, Aaron S., Mocellin, Simone, Pigozzo, Jacopo, Midena, Edoardo, Markovic, Svetomir N., Aliberti, Camillo, Campana, Luca G., Chiarion-Sileni, Vanna
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2015
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4363319/
https://ncbi.nlm.nih.gov/pubmed/25780931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0120181
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller